Skip to main content
Fig. 10 | Journal of Neuroinflammation

Fig. 10

From: Role of the indoleamine-2,3-dioxygenase/kynurenine pathway of tryptophan metabolism in behavioral alterations in a hepatic encephalopathy rat model

Fig. 10

Effects of the IDO inhibitor 1-MT (9 mg/kg) on the 5-hydroxyindoleacetic acid (5-HIAA)/5-HT ratio, 3-hydroxykynurenine (3-HK)/kynurenic acid (KA) ratio, and quinolinic acid (QA) levels in the hippocampus (a1, b1, c1) and cerebral cortex (a2, b2, c2) of BDL rats. Data are expressed as mean ± SEM (n = 6). *p < 0.05 and **p < 0.01, when compared to the sham group; #p < 0.05 and ##p < 0.01, when compared to the BDL group

Back to article page